4D MOLECULAR THERAPEUTICS IN

Ticker: FDMT CUSIP: 35104E100 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 27,758 Value ($000) $208 Avg Close $10.14 Range $7.43 - $12.34
Q3 2025
Shares 145,907 Value ($000) $1,268 Avg Close $5.98 Range $3.68 - $8.72
Q2 2025
Shares 257,620 Value ($000) $956 Avg Close $3.52 Range $2.23 - $5.10
Q1 2025
Shares 158,288 Value ($000) $511 Avg Close $4.71 Range $3.17 - $6.91
Q4 2024
Shares 52,744 Value ($000) $294 Avg Close $7.85 Range $5.22 - $10.78
Q3 2024
Shares 165,193 Value ($000) $1,786 Avg Close $16.60 Range $10.56 - $28.93
Q2 2024
Shares 185,866 Value ($000) $3,901 Avg Close $25.09 Range $20.33 - $31.87
Q1 2024
Shares 257,746 Value ($000) $8,212 Avg Close $25.51 Range $16.64 - $36.25
Q1 2023
Shares 33,954 Value ($000) $584 Avg Close $19.45 Range $14.67 - $23.81
Q4 2022
Shares 69,747 Value ($000) $1,549 Avg Close $15.45 Range $6.58 - $26.49
Q4 2021
Shares 3,317 Value ($000) $73 Avg Close $24.51 Range $18.57 - $34.00
Q1 2021
Shares 18,760 Value ($000) $814 Avg Close $44.29 Range $34.00 - $55.11
Q4 2020
Shares 7,436 Value ($000) $308 Avg Close $41.28 Range $36.10 - $49.06